Compound 613
Identifiers
- Canonical SMILES:
OC(=O)Cc1ccc(Cl)c(F)c1-n1c(nc(C(=O)OCc2ccccc2)c1-c1ccc(F)c(Cl)c1)C1CCCCCC1
- InChi:
InChI=1S/C32H28Cl2F2N2O4/c33-23-14-12-22(17-26(39)40)29(27(23)36)38-30(21-13-15-25(35)24(34)16-21)28(32(41)42-18-19-8-4-3-5-9-19)37-31(38)20-10-6-1-2-7-11-20/h3-5,8-9,12-16,20H,1-2,6-7,10-11,17-18H2,(H,39,40)
- InChiKey:
ZFGWXPREFUTQCN-UHFFFAOYSA-N
External links
67954312 |
External search
Bibliography (1)
Pharmacological data
Biochemical tests | Cellular tests | PK tests | Cytotoxicity tests |
---|---|---|---|
1 | 0 | 0 | 0 |
Targets
PPI family | Best activity | Diseases | MMoA |
---|---|---|---|
MDM2-Like / P53 | 7.09 | cancer | Inhibition |
Physicochemical filters
Descriptor | Lipinski's RO5 | Veber | Pfizer's 3/75 | |
---|---|---|---|---|
Compliance | ||||
MW | 612.14 g/mol | |||
HBA | 6 | |||
HBD | 1 | |||
HBA + HBD | 7 | |||
AlogP | 7.43 | |||
TPSA | 81.42 | |||
RB | 8 |
Radar chart
PCA : iPPI-DB chemical space
PCA : Correlation circle
Efficiencies: iPPI-DB biplot LE versus LLE
Summary
Bibliographic ressources | Biochemical tests | Cellular tests | PK tests | Cytotoxicity tests |
---|---|---|---|---|
1 | 1 | 0 | 0 | 0 |
Pharmacological data
Bibliography | Name | Target | Competition | Assay type | Assay name | Cell line | Activity type | Activity |
---|---|---|---|---|---|---|---|---|
WO2011023677 | 518 | MDM2 Q00987 |
|
Biochemical assay | Time-Resolved FRET | pIC50 (half maximal inhibitory concentration, -log10) | 7.09 |
Ta | Structure | Name | Drugbank ID |
---|---|---|---|
0.4643 | Azeliragon | DB12689 | |
0.4518 | 2-CHLORO-5-(3-CHLORO-PHENYL)-6-[(4-CYANO-PHENYL)-(3-METHYL-3H-IMIDAZOL-4-YL)- METHOXYMETHYL]-NICOTINONITRILE | DB06953 | |
0.4428 | Ralimetinib | DB11787 | |
0.4424 | Flumazenil | DB01205 | |
0.4363 | Olmesartan | DB00275 | |
0.4355 | N-6022 | DB12206 | |
0.4259 | Velpatasvir | DB11613 | |
0.4235 | Atorvastatin | DB01076 | |
0.4108 | Cimicoxib | DB05095 | |
0.4108 | Losartan | DB00678 | |
0.4088 | LY-2584702 | DB12690 | |
0.4086 | Cyclohexyl-{4-[5-(3,4-Dichlorophenyl)-2-Piperidin-4-Yl-3-Propyl-3h-Imidazol-4-Yl]-Pyrimidin-2-Yl}Amine | DB02388 | |
0.4065 | Cyclopropyl-{4-[5-(3,4-Dichlorophenyl)-2-[(1-Methyl)-Piperidin]-4-Yl-3-Propyl-3h-Imidazol-4-Yl]-Pyrimidin-2-Yl}Amine | DB03084 | |
0.4062 | Telmisartan | DB00966 | |
0.4051 | Otenabant | DB11745 |